Practice Profile: Corporate partner Gareth Clark focuses on international private equity and M&A deals, such as leveraged buyouts, carve-out transactions, growth capital investments, going-private transactions and divestitures. Over the past year, Mr. Clark has guided Cerberus Capital Management through the sale of California biotech PaxVax to Emergent Biosolutions, a complex cross-border deal touching on multiple jurisdictions, and coordinated the global team shepherding One Equity Partners and its portfolio company, PeroxyChem, through the pending $625 million sale of PeroxyChem to Germany’s Evonik Industries. Also over the past year, he played a key role in representing NASDAQ-listed Centric Brands (f/k/a Differential Brands Group) in its acquisition of a significant part of the North American licensing business of Hong Kong-listed Global Brands Group, a US$1.2 billion carve-out deal that spanned three continents and multiple practice areas.

Leadership, Pro Bono and Civic Work: Mr. Clark sits on Dechert’s hiring committee and co-chairs its LGBTQ affinity group, which recently launched a mentoring program for LGBTQ law students at various New York law schools, including Columbia, Fordham and NYU. He also serves as Co-Diversity Liaison Partner for the firm’s corporate department, which helps him ensure that diverse attorneys are considered for leadership positions and included on client pitches and key deals.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]